Plant Comparison
Water Hyssop vs Oregon Grape
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Water Hyssop and Oregon Grape: they share 4 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Water Hyssop | Oregon Grape | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 7/10 | Stronger for Oregon Grape |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 7/10 | Stronger for Oregon Grape |
| Skin irritation | 1/10 | 8/10 | Stronger for Oregon Grape |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Pharmacological Actions
Bacopa monnieri (Brahmi) extract and its saponins (bacopaside II, bacopasaponins) inhibit proliferation and induce apoptosis in colon and lung cancer cells (preclinical).
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Bacopaside II from Bacopa monnieri inhibits colon cancer cell growth via cell-cycle arrest and apoptosis (aquaporin-1 blockade), and its bacopasaponins are cytotoxic to lung (PC9) and colon (SW620) cancer cells (preclinical).
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
Topical for atopic dermatitis (eczema) and skin irritation
Antimicrobial (berberine) - supports skin and mucosal infection
inferred from anti-inflammatory action
Anti-inflammatory and antiproliferative (slows the skin-cell overgrowth of psoriasis); Topical treatment of mild-to-moderate psoriasis (reduces plaque severity) - a double-blind, placebo-controlled RCT showed significant improvement in PASI and quality-of-life scores
Topical for atopic dermatitis (eczema) and skin irritation
Safety, Cautions & Contraindications
Generally well tolerated at standard doses. The most commonly reported side effects are gastrointestinal — nausea, stomach cramps, and increased bowel movements — which can be reduced by taking with food. Not recommended during pregnancy. May interact with medications that increase acetylcholine levels (e.g. Alzheimer's medications). Use with caution in thyroid conditions, as bacopa may increase thyroid hormone levels.
Avoid internal use in pregnancy and breastfeeding: like goldenseal, the berberine it contains can cross the placenta and into milk and worsen newborn jaundice (kernicterus risk).
External Ids
Botanical Description
Low, creeping, succulent perennial herb that roots at the nodes as it spreads across wet ground. The leaves are small, fleshy, spatula-shaped and arranged oppositely along the trailing stems. Small, pale lavender to white, four- to five-petalled flowers are borne singly in the leaf axils.[4]
Evergreen shrub, 0.5-2 m tall, spreading by underground rhizomes to form thickets. The pinnate leaves resemble holly, with 5-9 glossy, dark green, spiny-toothed leaflets that often turn bronze-red in winter. Small, bright yellow, six-petalled flowers are borne in dense, upright terminal racemes in early spring, followed by clusters of blue-black, grape-like berries with a waxy bloom. The wood and inner bark of the stem and root are bright yellow when cut, owing to their high content of berberine-type alkaloids.
Habitat
Grows in wet, marshy ground, muddy shorelines, rice paddies and shallow water throughout tropical and subtropical regions of Asia, and also found in parts of Africa, Australia and the Americas.[4]
Native to the Pacific Northwest of North America, growing in coniferous woodland understorey, forest margins and rocky slopes; widely introduced and naturalised as an ornamental and hedging shrub in temperate regions elsewhere.
Harvesting
The whole plant (leaf and trailing stem) is harvested during active growth, typically cut a few centimetres above the mud or water line, and dried or used fresh.
The root and root bark, the medicinal parts, are dug from established plants - traditionally in autumn - and dried. Because wild populations are slow-growing, cultivated or nursery-sourced material is preferred over wild-harvesting.
Traditional Uses
Bacopa (brahmi) is a classic Ayurvedic 'medhya rasayana' (brain-nourishing) herb, traditionally used to support memory, learning and mental clarity, and as a calming nervine for anxiety and disturbed sleep. This traditional cognitive reputation is now supported by randomised controlled trials of standardised extracts.[1, 4]
Oregon grape root has a traditional Native American and Eclectic-medicine history as a bitter tonic and alterative (blood-purifying) remedy and for skin conditions. Its main modern use, supported by clinical trials, is topical application of a standardised bark extract for mild-to-moderate psoriasis and atopic dermatitis (eczema), where its berberine-type alkaloids give anti-inflammatory and antiproliferative effects on skin cells.[1, 11, 12]
Preparations
Dosage
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Calabrese, C., Gregory, W.L., Leo, M., Kraemer, D. et al (2008) 'Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial', Journal of Alternative and Complementary Medicine, 14(6), pp. 707-713. doi:10.1089/acm.2008.0018 Randomized trial
https://doi.org/10.1089/acm.2008.0018 - Lorca, C., Mulet, M., Arévalo-Caro, C., Sanchez, M.Á. et al (2022) 'Plant-derived nootropics and human cognition: A systematic review', Critical Reviews in Food Science and Nutrition, 63(22), pp. 5521-5545. doi:10.1080/10408398.2021.2021137 Meta-analysis / review
https://doi.org/10.1080/10408398.2021.2021137 - Fatima, U., Roy, S., Ahmad, S., Ali, S. et al (2022) 'Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation', Frontiers in Nutrition, 9, pp. 972379. doi:10.3389/fnut.2022.972379 Traditional / reference
https://doi.org/10.3389/fnut.2022.972379 - Kongkeaw, C., Dilokthornsakul, P., Thanarangsarit, P., Limpeanchob, N. and Norman Scholfield, C (2014) 'Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract', Journal of Ethnopharmacology, 151(1), pp. 528-535. doi:10.1016/j.jep.2013.11.008 Meta-analysis / review
https://doi.org/10.1016/j.jep.2013.11.008 - Vinod, A., Sathianarayanan, S., Babu, A.E., Sadanandan, P., Venu, A.K. and Venkidasamy, B (2022) 'Bacopa monnieri for disorders affecting brain: current perspectives', Current Topics in Medicinal Chemistry, 22(23), pp. 1909-1929. doi:10.2174/1568026622666220119111538 Meta-analysis / review
https://doi.org/10.2174/1568026622666220119111538 - Dubey, T., Kushwaha, P., Thulasiram, H.V., Chandrashekar, M. and Chinnathambi, S (2023) 'Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells', International Journal of Biological Macromolecules, 234, pp. 123171. doi:10.1016/j.ijbiomac.2023.123171 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.123171 - Shalini, V.T., Neelakanta, S.J. and Sriranjini, J.S (2021) 'Neuroprotection with Bacopa monnieri - a review of experimental evidence', Molecular Biology Reports, 48(3), pp. 2653-2668. doi:10.1007/s11033-021-06236-w Meta-analysis / review
https://doi.org/10.1007/s11033-021-06236-w - Simpson, T., Pase, M. and Stough, C (2015) 'Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain', Evidence-Based Complementary and Alternative Medicine, 2015, pp. 615384. doi:10.1155/2015/615384 Meta-analysis / review
https://doi.org/10.1155/2015/615384 - Saini, N., Singh, D. and Sandhir, R (2019) 'Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action', Metabolic Brain Disease, 34(2), pp. 505-518. doi:10.1007/s11011-018-0332-1 Preclinical
https://doi.org/10.1007/s11011-018-0332-1 - Dubey, T. and Chinnathambi, S (2019) 'Brahmi (Bacopa monnieri): an ayurvedic herb against the Alzheimer's disease', Archives of Biochemistry and Biophysics, 676, pp. 108153. doi:10.1016/j.abb.2019.108153 Meta-analysis / review
https://doi.org/10.1016/j.abb.2019.108153 - Bhandari, P., Kumar, N., Singh, B. and Kaul, V.K (2007) 'Cucurbitacins from Bacopa monnieri', Phytochemistry, 68(9), pp. 1248-1254. doi:10.1016/j.phytochem.2007.03.013 Preclinical
https://doi.org/10.1016/j.phytochem.2007.03.013 - Sivaramakrishna, C., Rao, C.V., Trimurtulu, G., Vanisree, M. and Subbaraju, G.V (2005) 'Triterpenoid glycosides from Bacopa monnieri', Phytochemistry, 66(23), pp. 2719-2728. doi:10.1016/j.phytochem.2005.09.016 Preclinical
https://doi.org/10.1016/j.phytochem.2005.09.016 - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Smith, E. and Palethorpe, H.M. and Tomita, Y. and Pei, J.V. and Townsend, A.R. and Price, T.J. and Young, J.P. and Yool, A.J. and Hardingham, J.E (2018) 'The Purified Extract from the Medicinal Plant Bacopa monnieri, Bacopaside II, Inhibits Growth of Colon Cancer Cells In Vitro by Inducing Cell Cycle Arrest and Apoptosis', Cells, 7(7), pp. 81. doi:10.3390/cells7070081 Preclinical
https://doi.org/10.3390/cells7070081 - Yen, D.T.H. and Cuc, N.T. and Tai, B.H. and Van Kiem, P. and Hoang Duc, M. and Nhiem, N.X. and Cho, S.-H. and Jeong, S.B. and Seo, Y. and Park, S (2022) 'Two new triterpenoid glycosides from Bacopa monnieri and their cytotoxic activity', Natural Product Research, 38(7), pp. 1120-1126. doi:10.1080/14786419.2022.2132498 Preclinical
https://doi.org/10.1080/14786419.2022.2132498 - Calabrese, C., Gregory, W.L., Leo, M., Kraemer, D., Bone, K. and Oken, B (2008) 'Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly', 14(6), pp. 707--713. Randomized trial
https://scholar.google.com/scholar?q=Effects%20of%20a%20standardized%20Bacopa%20monnieri%20extract%20on%20cognitive%20performance%2C%20anxiety%2C%20and%20depression%20in%20the%20elderly - Stough, C., Lloyd, J., Clarke, J., Downey, L.A., Hutchison, C.W., Rodgers, T. and Nathan, P.J (2001) 'The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects', 156(4), pp. 481--484. doi:10.1007/s002130100815 Randomized trial
https://doi.org/10.1007/s002130100815 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Gulliver, W.P. and Donsky, H.J (2005) 'A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis', American Journal of Therapeutics, 12(5), pp. 398-406. doi:10.1097/01.mjt.0000174350.82270.da Clinical study
https://doi.org/10.1097/01.mjt.0000174350.82270.da - Cernakova, M. and Kostalova, D (2002) 'Antimicrobial activity of berberine--a constituent of Mahonia aquifolium', Folia Microbiologica, 47(4), pp. 375-378. doi:10.1007/BF02818693 Preclinical
https://doi.org/10.1007/BF02818693 - Damjanovic, A., Kolundzija, B., Matic, I.Z., Krivokuca, A. and others (2020) 'Mahonia aquifolium Extracts Promote Doxorubicin Effects against Lung Adenocarcinoma Cells In Vitro', Molecules, 25(22), pp. 5233. doi:10.3390/molecules25225233 Preclinical
https://doi.org/10.3390/molecules25225233 - Cernakova, M., Kostalova, D., Kettmann, V., Plodova, M. and others (2002) 'Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium', BMC Complementary and Alternative Medicine, 2, pp. 2. doi:10.1186/1472-6882-2-2 Preclinical
https://doi.org/10.1186/1472-6882-2-2 - Slobodnikova, L., Kostalova, D., Labudova, D., Kotulova, D. and Kettmann, V (2004) 'Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids', Phytotherapy Research, 18(8), pp. 674-676. doi:10.1002/ptr.1517 Preclinical
https://doi.org/10.1002/ptr.1517 - Godjevac, D., Damjanovic, A., Stanojkovic, T.P., Andjelkovic, B. and Zdunic, G (2018) 'Identification of cytotoxic metabolites from Mahonia aquifolium using 1H NMR-based metabolomics approach', Journal of Pharmaceutical and Biomedical Analysis, 150, pp. 9-14. doi:10.1016/j.jpba.2017.11.075 Preclinical
https://doi.org/10.1016/j.jpba.2017.11.075 - Muller, K. and Ziereis, K (1994) 'The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase', Planta Medica, 60(5), pp. 421-424. doi:10.1055/s-2006-959523 Preclinical
https://doi.org/10.1055/s-2006-959523 - Rohrer, U., Kunz, E.M.K., Lenkeit, K., Schaffner, W. and Meyer, J (2007) 'Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria', Schweizer Monatsschrift fur Zahnmedizin, 117(11), pp. 1126-1131. Preclinical
https://scholar.google.com/scholar?q=Antimicrobial%20activity%20of%20Mahonia%20aquifolium%20and%20two%20of%20its%20alkaloids%20against%20oral%20bacteria - Vollekova, A., Kostalova, D., Kettmann, V. and Toth, J (2003) 'Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids', Phytotherapy Research, 17(7), pp. 834-837. doi:10.1002/ptr.1256 Preclinical
https://doi.org/10.1002/ptr.1256 - Hajnicka, V., Kostalova, D., Svecova, D., Sochorova, R. and others (2002) 'Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1', Planta Medica, 68(3), pp. 266-268. doi:10.1055/s-2002-23126 Preclinical
https://doi.org/10.1055/s-2002-23126 - Gulliver, W.P. and colleagues (2018) 'Review of the Efficacy and Safety of Topical Mahonia aquifolium for the Treatment of Psoriasis and Atopic Dermatitis', Journal of Clinical and Aesthetic Dermatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ Meta-analysis / review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334833/ - Herbal Reality (n.d.) 'Oregon Grape Root (Berberis aquifolium): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/oregon-grape/ Traditional / reference
https://www.herbalreality.com/herb/oregon-grape/ - Bernstein, S., Donsky, H., Gulliver, W., Hamilton, D., Nobel, S. and Norman, R (2006) 'Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract - a double-blind, placebo-controlled study', American Journal of Therapeutics, 13(2), pp. 121--126. doi:10.1097/00045391-200603000-00007 Randomized trial
https://doi.org/10.1097/00045391-200603000-00007
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.